MedPath
FDA Approval

Chloroquine Phosphate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 9, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Chloroquine(500 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Suven Pharmaceuticals Limited

861468675

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited

677604288

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chloroquine Phosphate

Product Details

NDC Product Code
68022-0265
Application Number
ANDA214756
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 9, 2024
Code: 6E17K3343PClass: ACTIBQuantity: 500 mg in 1 1

Chloroquine Phosphate

Product Details

NDC Product Code
68022-0264
Application Number
ANDA214756
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 9, 2024
Code: 6E17K3343PClass: ACTIBQuantity: 500 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath